# Phase 2 hypersensitivity trials recruiting: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials in phase 2 for hypersensitivity that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 hypersensitivity trials: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/hypersensitivity

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 23, 2026 | NCT07891780 | Pharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy Patients | Hikma Pharmaceuticals USA Inc. | Phase 2 | Not yet recruiting | Epinephrine, Hypersensitivity, Immediate, Anaphylaxis | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891780) |
| September 11, 2026 | NCT07816432 | A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With... | Longbio Pharma (Suzhou) Co., Ltd. | Phase 2 | Not yet recruiting | Food Allergy, Wheat Hypersensitivity | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816432) |
| August 25, 2026 | NCT07785063 | Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients | Longbio Pharma (Suzhou) Co., Ltd. | Phase 2 | Not yet recruiting | Peanut Allergies | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785063) |
| May 28, 2026 | NCT07611435 | Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Recruiting | Alpha-Gal Syndrome, Allergy | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07611435) |
| May 19, 2026 | NCT07595367 | Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity... | Sponsor not shown (see the record) | Phase 2 | Recruiting | Allergic Reaction (IgA) Vasculitis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595367) |
| March 24, 2026 | NCT07490587 | To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune... | Sponsor not shown (see the record) | Phase 2 | Recruiting | Healthy Children | 366 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07490587) |
| February 27, 2026 | NCT07439406 | Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 | Not yet recruiting | Peanut Allergy | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439406) |
| September 12, 2025 | NCT07170540 | UNC Cashew Sublingual Immunotherapy | University of North Carolina, Chapel Hill | Phase 2 | Not yet recruiting | Cashew Nut Allergy, Tree Nut Allergies | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07170540) |
| July 10, 2025 | NCT07059091 | Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD | Johns Hopkins University | Phase 2 | Recruiting | Chronic Obstructive Pulmonary Disease (COPD), Allergies | 334 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07059091) |
| June 11, 2025 | NCT07015996 | Efficacy of Tezepelumab in Peanut Oral Immunotherapy | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Recruiting | Peanut Allergy | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07015996) |
| May 18, 2025 | NCT06977581 | A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma | Pfizer | Phase 2 | Recruiting | Asthma | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06977581) |
| April 24, 2025 | NCT06943534 | Omalizumab Weight-Based Dosing Efficacy Trial | Massachusetts General Hospital | Phase 2 | Recruiting | Allergies, Food Allergy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06943534) |
| April 18, 2025 | NCT06934200 | Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels | Johns Hopkins University | Phase 2 | Recruiting | Food Hypersensitivity | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06934200) |
| December 16, 2024 | NCT06734884 | Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome) | University Hospital, Lille | Phase 2 | Not yet recruiting | DRESS Syndrome | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06734884) |
| June 21, 2024 | NCT06467994 | Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children | Chinese University of Hong Kong | Phase 2 | Recruiting | Food Allergy in Children, Food Allergy | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06467994) |
| May 9, 2024 | NCT06406114 | Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing | Massachusetts General Hospital | Phase 2 | Recruiting | Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity, Antibiotic Allergy, Beta Lactam Adverse Reaction... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06406114) |
| April 17, 2024 | NCT06372249 | A Clinical Trial of Soluble Fiber for Asthma | Phoenix Children's Hospital | Phase 2 | Recruiting | Asthma in Children | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06372249) |
| January 23, 2023 | NCT05695261 | Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients | Sponsor not shown (see the record) | Phase 2 | Recruiting | Allergy, Peanut, Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Food Allergy, Food Allergy Peanut | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05695261) |
| April 15, 2022 | NCT05331170 | Viral Mucosal Reprogramming | The University of Texas Medical Branch, Galveston | Phase 2 | Recruiting | Asthma, Allergic Rhinitis, Cat Allergy, Healthy | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05331170) |
| August 9, 2021 | NCT04996875 | (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | Cogent Biosciences, Inc. | Phase 2 | Recruiting | Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL)... | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04996875) |
| February 11, 2019 | NCT03835767 | Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Recruiting | Milk and/or Peanut Allergy | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03835767) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Massachusetts General Hospital | 2 |
| Johns Hopkins University | 2 |
| Longbio Pharma (Suzhou) Co., Ltd. | 2 |
| Chinese University of Hong Kong | 1 |
| Phoenix Children's Hospital | 1 |
| Cogent Biosciences, Inc. | 1 |
| University Hospital, Lille | 1 |
| The University of Texas Medical Branch, Galveston | 1 |
| Hikma Pharmaceuticals USA Inc. | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| University of North Carolina, Chapel Hill | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 16 |
| China | 5 |
| Canada | 3 |
| Australia | 2 |
| Belgium | 2 |
| France | 2 |
| Italy | 2 |
| Poland | 2 |
| Spain | 2 |
| United Kingdom | 2 |
| Malaysia | 1 |
| Hong Kong | 1 |
| Austria | 1 |
| Germany | 1 |
| Netherlands | 1 |
| Norway | 1 |
| Switzerland | 1 |
| Argentina | 1 |
| Bulgaria | 1 |
| Czechia | 1 |
| Hungary | 1 |
| Japan | 1 |
| South Africa | 1 |
| South Korea | 1 |
| Taiwan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Trailer repair shops in the United States](https://specstream.ai/data/businesses/trailer-repair-shops/united-states)
- [Home inspectors in the United States](https://specstream.ai/data/businesses/home-inspectors/united-states)
- [3D printing companies in the United States](https://specstream.ai/data/businesses/3d-printing-companies/united-states)
- [Kitchen supply stores in the United States](https://specstream.ai/data/businesses/kitchen-supply-stores/united-states)
- [B2B marketing consultants in the United States](https://specstream.ai/data/businesses/b2b-marketing-consultants/united-states)
- [Mongolian restaurants in the United States](https://specstream.ai/data/businesses/mongolian-restaurants/united-states)
